🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The present pilot study is designed to assess the extent to which rasagilin...
Status
Completed
Location
Georgetown University Hospital
Start Date
2012-01
Trial ID
NCT01497652
Treatments Being Tested
The purpose of this study is to find out if rasagiline improves RLS symptom...
Status
Terminated
Location
Advent Research
Start Date
2010-09
Trial ID
NCT01192503
Treatments Being Tested
The rationale for conducting this study is to evaluate the efficacy, tolera...
Status
Completed
Location
CN015
Start Date
2011-12
Trial ID
NCT01479530
Pain (spontaneous pain) is a fundamental non-motor symptom (NMS) of Parkins...
Status
Unknown
Location
Azienda ospedaliera universitaria integrata verona
Start Date
2018-03-28
Trial ID
NCT03648671
This study will evaluate an oral fixed-dose, once daily product that combin...
Status
Completed
Location
P2B001 Site Birmingham
Start Date
2013-12
Trial ID
NCT01968460
In this investigator-initiated study, we will compare changes in brain cogn...
Status
Completed
Location
University at Buffalo
Start Date
2014-11
Trial ID
NCT02278588
Treatments Being Tested
While Parkinson's disease has historically been defined in terms of its mot...
Status
Completed
Location
Butler Hospital
Start Date
2011-06
Trial ID
NCT01382342
Treatments Being Tested
This is a one year, 2-part study to determine the efficacy and safety of pr...
Status
Terminated
Location
Multiple Locations
Start Date
2010-07-06
Trial ID
NCT01155479
A decrease or loss of the sense of smell is very common in patients with Pa...
Status
Unknown
Location
The Parkinson's Institute
Start Date
2009-11
Trial ID
NCT01007630
Treatments Being Tested
P2B001 is an investigational drug that comprised of low doses of two drugs,...
Status
Completed
Location
P2B001/003 Site Scottsdale
Start Date
2018-01-19
Trial ID
NCT03329508
Treatments Being Tested